Cancer
Research on cancer described by scientists at University of Parma
Published in Gene Therapy Weekly, January 17th, 2008
"The possible differential roles played by the two clusterin forms in growth and motility of nonmalignant and malignant prostate cells are investigated here. sCLU or nCLU was transiently transfected in both androgen-independent prostate cancer cells (PC3 and DU 145) and immortalized prostate epithelial cells (PNT1A, a nontumoral control)," wrote R.M. Moretti and colleagues, University of Parma.
The researchers concluded: "Then, cell growth,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2008-01-17)
More Articles from Gene Therapy Weekly
- Cancer Gene Therapy
Study data from G.I. Bauerschmitz et al provide new insights into cancer gene therapy - Central Nervous System Disorders
Data on central nervous system disorders published by researchers at National Institute of Neurological Disorders and Stroke - Colon Cancer
Findings from INSERM advance knowledge in colon cancer - Colon Cancer
New colon cancer study findings have been reported from Baylor University - Enzyme Research
Research from Keio University, Medical Department provide new insights into enzyme research - Gene Therapy
Investigators at Hebrew University zero in on gene therapy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
